Advertisement : Ads.Google.com

U.S. FDA

“Dr. Nagel, you kind of answered in your presentation the FDA’s efforts towards breast implant safety registry’s tracking but maybe I could just ask a clarification question based on your presentation, with regards to the [FDA] update from September 8th…

SANTA BARBARA, Calif., July 06, 2022 (GLOBE NEWSWIRE) — Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”) announced today that the U.S. Food and Drug Administration (FDA) approved the Low Plus Profile Projection Breast Implant for breast augmentation in women at least…

© 2024 Surgical Times. All Rights Reserved.